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iNKT cells are a subset of innate T cells that recog-
nize glycolipids presented on CD1d molecules
and protect against bacterial infections, including
S. pneumoniae. Using lung intravital imaging, we
examined the behavior andmechanism of pulmonary
iNKT cell activation in response to the specific iNKT
cell ligand a-galactosylceramide or S. pneumoniae
infection. In untreated mice, the major fraction of
iNKT cells resided in the vasculature, but a small crit-
ical population resided in the extravascular space in
proximity to monocyte-derived DCs. Administration
of either a-GalCer or S. pneumoniae induced CD1d-
dependent rapid recruitment of neutrophils out of
the vasculature. The neutrophils guided iNKT cells
from the lung vasculature via CCL17. Depletion of
monocyte-derived DCs abrogated both the neutro-
phil and subsequent iNKT cell extravasation. More-
over, impairing iNKT cell recruitment by blocking
CCL17 increased susceptibility to S. pneumoniae
infection, suggesting a critical role for the influx of
iNKT cells in host defense.
INTRODUCTION
Invariant natural killer T (iNKT) cells are innate-like immune cells
capable of robustly producing a variety of cytokines and anti-
microbial molecules (Gao and Williams, 2015), allowing these
cells to bridge the gap between innate and adaptive immunity.
Subsets of iNKT cells have been identified (NKT1, NKT2, and
NKT17) based on the types of cytokines they produce in
response to lipid antigens such as the prototypical a-galactosyl-
ceramide (a-Galcer) (Lee et al., 2015). Strategic localization of
these cells matters. Using an immunohistochemistry approach,
Lee et al. (2015) demonstrated that different percentages of
iNKT cell subpopulations were found in different parts of individ-3260 Cell Reports 16, 3260–3272, September 20, 2016 ª 2016 The A
This is an open access article under the CC BY-NC-ND license (http://ual organs such as the spleen. NKT1 cells localized preferentially
in the red pulp of the spleen, whereas NKT2 cells were in the
T cell zone of the white pulp. Administration of a-GalCer intrave-
nously (i.v.) activated the intravascular iNKT cells more readily
than the parenchymal iNKT cells of the spleen, highlighting the
importance of spatial arrangement (Lee et al., 2015).
There is a growing body of evidence that suggests that iNKT
cell distribution is also unique in each organ and closely corre-
lated with function. For example, in the liver, iNKT cells reside
in the vasculature and patrol the sinusoids. In this way they
can sample local changeswithin blood vessels aswell as interact
with intravascular liver macrophages known as Kupffer cells.
Kupffer cells have a remarkable ability to catch bacteria from
the mainstream of blood and then present glycolipids derived
from these pathogens to the patrolling iNKT cells. This induces
iNKT cells to arrest movement (a hallmark of activation) and
begin producing interferon-g to help drive inflammation (Lee
et al., 2010). However, their localization in the blood may also
reflect their ability to detect distant organ injury and rapidly alter
whole-body immunity status. For example, induction of stroke
led to the release of molecules that were rapidly detected by
intravascular iNKT cells, leading to cessation of cell movement
and the production of interleukin-10 (IL-10). This led to the damp-
ening of whole-body inflammation and an increased susceptibil-
ity to infection (Wong et al., 2011). Unlike the liver, iNKT cells did
not patrol the blood vessels of joints (Lee et al., 2014). Instead,
iNKT cells were strategically localized extravascularly along the
length of the few blood vessels within the joint (Lee et al.,
2014). Upon infection with Borrelia burgdorferi, which adhered
to the joint vasculature, iNKT cells were able to recognize and
directly kill this pathogen and prevent infection (Lee et al.,
2014). Interestingly, in the liver, iNKT cells reside inside the
vasculature, whereas, in the joints, they reside outside, and,
upon stimulation, their compartmentalization does not change
(Lee et al., 2010, 2014).
To date, very little is known about the behavior and localization
of iNKT cells in the lungs despite their importance in numerous
pulmonary diseases. Antibody-mediated in vivo labeling fol-
lowed by rapid isolation of cells from whole organs gives valuesuthor(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
for intravascular versus parenchymal distribution of iNKT cells
(Scanlon et al., 2011; Lee et al., 2015). Using this approach
with histocytometry, the lung parenchyma appears to mostly
harbor NKT17 cells, whereas the blood compartment of the
lung contains NKT1 cells (Lee et al., 2015). In another study of ex-
planted lung, Scanlon et al. (2011) reported that some iNKT cells
were in the vasculature, whereas the remainder was likely in the
parenchyma. The limitation of non-live-cell imaging techniques
is that they fail to capture the migrational dynamics of iNKT cells
in tissues. However, live cell imaging of the lung is complicated
by several factors, such as its relative inaccessibility and the
gross movement of the organ. It is therefore not surprising that
there is a dearth of information describing the distribution,
behavior, migrational dynamics, and specialized functions of
pulmonary iNKT cells. In addition to iNKT cells, there is a resident
population of intravascular neutrophils in the lungs (Kreisel et al.,
2010). Because both neutrophils and iNKT cells play critical roles
in the lung under situations of S. pneumoniae infection, imaging
could also unveil potential interactions or relationships between
these cell types (Kawakami et al., 2003; Wilson et al., 2015).
The lung is in constant contact with the outside environment
via the airways, allowing environmental particulates and
pathogens easy access to the pulmonary tissue. Pulmonary
macrophages housed inside the alveoli are the first line of
defense against bacterial dissemination. When pathogens enter
the interstitium, interstitial sentinel cells of unknown origin
could potentially recruit immune cells from the vasculature to
prevent further invasion. However, the interstitial space that
separates the alveoli and the capillaries is only a few microns
in thickness, permitting effective oxygen transport into the
blood stream. Any infection that reaches the interstitial space
must be rapidly eradicated without excessive inflammation
and edema so that oxygen transport can continue. Recent
work using two-photon microscopy has allowed visualization
of the behavior of immune cells in the lung (Looney et al.,
2011; Bose et al., 2015). In this study, we imaged the pulmo-
nary vasculature surrounding the alveoli using a multichannel
spinning disk confocal microscope (intravital microscopy
[IVM]), which permitted visualization of iNKT cells within and
outside the vasculature under basal conditions and following
a-GalCer or Streptococcus pneumoniae. We also identified
key interactions of iNKT cells with neutrophils and monocyte-
derived dendritic cells (DCs).
RESULTS
iNKT Cells Reside in Both the Lung Vasculature and the
Lung Interstitial Parenchyma
Positioning a small window with gentle suction on an otherwise
normally respiring lung of a live anesthetized mouse allowed
visualization using IVM over extended periods of time in vivo
without motion artifacts (Looney et al., 2011). The lung continued
to be ventilated with air, and the blood within the vasculature
continued to flow around the alveoli (Movie S1). Importantly,
platelet aggregation and adhesion, a hallmark of inflammation
and endothelial activation, was not seen in the lung vasculature
during basal imaging sessions (data not shown). Our initial visu-
alization of the pulmonary vasculature revealed a very dynamicenvironment with extremely dense microvasculature with many
overlapping vessels.
To date, the best tool to visualize iNKT cells in vivo is by using a
CXCR6GFP+ transgenic mouse (Scanlon et al., 2011; Wong et al.,
2011). Using whole-mount staining techniques, we found that
the brightest green cells per field of view (FOV) were also PBS-
57-loaded CD1d tetramer-positive (referred to hereafter as
‘‘tetramer’’) iNKT cells. In a 203 FOV, 60%–70% of CXCR6GFP+
cells were tetramer-positive iNKT cells (Figure S1A). CXCR6GFP+
cells that were tetramer-negative included a variety of T cells,
NK cells, and, possibly, innate-like lymphoid cells (Figure S1B).
Using IVM, we found that the lung had ample CXCR6GFP+ iNKT
cells inside very fast-flowing capillaries (Movie S1).
Many of the iNKT cells were observed in the blood stream
because they conformed to the size of the capillaries, they often
appeared suddenly (tethering to the endothelium from the main-
stream of blood), the majority of crawling and adherent iNKT
cells were often rapidly displaced some distance because of
high shear in the blood vessels, and theywould rapidly disappear
as they detached from the vessel wall and re-entered the main-
stream of blood (Figure 1A; Movies S2, S3, and S4). A 3D recon-
struction clearly supported the notion that the majority of iNKT
cells were intravascular (Movie S5). Extensive detailed behav-
ioral examination of the iNKT cells revealed that approximately
40% of cells tethered, 20% crawled, and the remaining 40%
were stationary (Figure 1B). Two approaches were taken to iden-
tify the frequency of the cells that were intravascular versus
extravascular. We termed the first approach ‘‘shadowing,’’
where displacement of tetramethylrhodamine isothiocyanate
(TRITC)-dextran in the lumen of blood by cells produced an
unlit/dark area occupied by the cell. Thus, if a CXCR6GFP+
iNKT cell resided in the vasculature, then there would be a
shadow of the cell visible in the TRITC channel that conformed
to the size and shape of the GFP+ cell (Figure 1C; Auffray
et al., 2007). Approximately, 75%–80% of iNKT cells were in
the vasculature (Figure 1D).
The second approach to differentiate the spatial distribution of
cells was to use an i.v. infusion of anti-CD45 antibody (a pan
leukocyte marker) for a very brief period of time prior to the har-
vest of tissues. This technique only labels cells within the vascu-
lature (Barletta et al., 2012). The lungs were then harvested for
flow cytometric analysis. Almost all neutrophils were labeled
with anti-CD45, whereas no alveolar macrophages were labeled
(data not shown). This confirmed that only vascular but not tis-
sue-resident immune cells were labeled with this technique.
When quantifying the distribution of iNKT cells (identified using
CD1d tetramer staining), we observed that 80% of cells were
labeled with anti-CD45 and 20% were protected from labeling
(Figure 1E), further corroborating our intravital imaging data.
Pulmonary iNKT Cells Migrate into the Lung Interstitium
upon Activation
Intravenous administration of a-GalCer resulted in dramatic
changes to the behavior and phenotype of pulmonary iNKT cells.
3 hr after i.v. administration of a-Galcer, themajority of iNKT cells
crawled persistently for long lengths, and very few were
observed to tether (Figure 1B). Unexpectedly, from this time
point on up until 24 hr, iNKT cells began crossing the vascularCell Reports 16, 3260–3272, September 20, 2016 3261
Figure 1. iNKT Cells Reside Predominately in the Lung Vasculature, Migrating out upon Stimulation with Intravenous a-Galcer
(A) Three behaviors were observed for CXCR6GFP+ cells, identified by IVM in the lungs of untreated mice: (1) crawling, movement of cells back and forth; (2)
tethering, rapid movement of cells with blood flow with short 10- to 20-s stops and re-entering into the blood flow; and (3) stationary, cells show protrusion and
slight movement but stay in the general area for 1 min or longer. Green, CXCR6GFP+; red, TRITC-dextran. See also Figure S1A and Movies S1, S2, S3, and S4.
(B) Quantification of cell behaviors in vehicle-treated mice (UT) or mice treated with a-Galcer intravenously.
(C) Localization of cells was assessed using TRITC-dextran shadowing. The arrow indicates the shadow formed by CXCR6GFP+ cells.
(D) Localization of CXCR6GFP+ cells was assessed in naivemice (UT) or mice treated with a-Galcer intravenously. Extravascular CXCR6GFP+ cells take on a larger,
rounded phenotype and do not display shadows. See also Movie S5.
(E) Flow cytometry was used to assess cell localization of CD1d tetramer-positive cells. CD45 IV indicates cells that are intravascular. Low to negative CD45 IV
indicates extravascular localization. See also Figures S1B and S1C and S6.
(F) Dynamics of pulmonary iNKT cell activation based on mean fluorescence intensity of CD69 staining on tetramer-positive cells after intravenous a-Galcer
treatment.
Error bars represent SEM. *p < 0.05, **p < 0.01. n = 3–5 animals/group.barrier and moved into the extravascular space, where they ap-
peared much more flattened and larger in size (Figure 1D). Very
few iNKT cells were found in the bronchial-alveolar lavage (BAL)
fluid (discussed later). The increased appearance in size is
reflective of these cells being in the very narrow (1–3 mm) intersti-
tial space between the vasculature and the alveoli. By 24 hr,
approximately three quarters of the iNKT cells had extravasated3262 Cell Reports 16, 3260–3272, September 20, 2016into the interstitium, as assessed with the shadowing technique
(Figure 1D). Extravasating iNKT cells also upregulated the sur-
face expression of CD69, an early activation marker (Figure 1F).
Using the i.v. anti-CD45 infusion approach, we confirmed that
indeed 80% of pulmonary iNKT cells had extravasated out of
the vasculature (Figure 1E). When in the interstitium, the cells
became relatively stationary; they showed some movement
Figure 2. iNKT Cells Predominately Migrate to the Interstitial Space after Intratracheal Glycolipid Stimulation
(A) Mice were treated with aerosolized a-Galcer. iNKT cell localization was analyzed by flow cytometry using anti-CD45 i.v. injection.
(B) Localization of iNKT was quantified as in Figure 1E.
(C) Lungs of mice treated for 48 hr with aerosolized a-Galcer were removed, and whole-mount staining was performed. 3D reconstruction was performed to
assess the spatial localization of CCXR6GFP+ cells after treatment. Green, CXCR6GFP+ cells; red: CD31-stained endothelial cell; blue, Ly6G-stained neutrophils.
(D) The absolute cell counts for iNKT cells in the total lung homogenate and the bronchial-alveolar lavage fluid (BALF).
Error bars represent SEM. n = 3–5 animals/group. See also Figure S6A.but very little displacement (Movie S6). Interestingly, only
tetramer-positive CXCR6GFP+ cells (iNKT cells) crossed into
the interstitium after a-Galcer administration, whereas the
tetramer-negative (non-iNKT) cells did not respond to a-Galcer
administration (Figure S1C).
Because many pathogens enter the lung via the intratracheal
route, we next administered the a-GalCer via this route. Under
these conditions, the iNKT cell behavior was nearly identical
to i.v. a-Galcer, with approximately 80% of cells leaving the
vasculature and moving into the interstitium (Figures 2A and
2B; Movies S6 and S7). However, despite the intratracheal route
of a-Galcer administration, very few iNKT cells migrated into the
airspaces, confirmed by flow cytometric analysis of BAL fluid
(Figure 2D), indicating that these cells were retained predomi-
nately in the lung interstitial space. We used 3D modeling of
lung whole mount and found that, again, the iNKT cells clustered
and sat just above the vascular bed in the interstitial space (Fig-
ure 2C). The migration of iNKT cells occurred about 10 hr later,
when a-Galcer was administered intratracheally versus intrave-
nously. This delay likely reflects the difference in time that was
required for a-Galcer to cross the much tighter epithelial barrier
in airways and alveoli. There were minimal changes to the abso-lute number of iNKT cells in the lung 24 and 48 hr after a-Galcer
treatment, suggesting no new recruitment (Figure 2D). From
these data, we concluded that pulmonary iNKT cell dynamics
were similar whether the stimulus was given intratracheally or
intravenously, and we therefore used i.v. administration of
a-Galcer to assess the dynamics of iNKT cell activation.
Neutrophils Play an Important Role in iNKT Cell
Extravasation
Unexpectedly, i.v. administration of a-Galcer resulted in a robust
influx of neutrophils into the lung as early as 30 min, peaking at
2 hr, and stabilizing back to normal by 24 hr (Figure 3A). This
did not occur in other organs such as the spleen (Figure 3A).
Moreover, the recruited neutrophils rapidly moved out of the
vasculature into the interstitium and onward into the alveoli (Fig-
ure 3B and data not shown). Intravenous administration of
a-Galcer to CD1d knockout (CD1dKO) mice did not result in
increased recruitment of neutrophils, demonstrating that this
was a CD1d-dependent event and not an artifact of lipopolysac-
charide (LPS) or other neutrophil stimulant contamination
(Figure 3C). Similar recruitment of neutrophils could also be
observed when a-GalCer was given intratracheally (Figure S2A).Cell Reports 16, 3260–3272, September 20, 2016 3263
Figure 3. a-Galcer Treatment Results in an
Early Influx of Neutrophils that Are Neces-
sary for iNKT Cell Migration out of the
Vasculature
(A) Flow cytometry was utilized to determine the
dynamics of neutrophil influx in the lung and spleen
after i.v. a-Galcer treatment. The graphs represent
the frequency of neutrophils as a percentage of
CD45+ cells. See also Figure S2A.
(B) Extravasation of neutrophils after a-Galcer
treatment as in Figure 1E.
(C) Quantification of neutrophil percentages in total
lung homogenate of CD1dKO mice and wild-type
littermates.
(D) Representative IVM images after 24 hr of
a-Galcer treatment in isotype control and neutro-
phil-depleted mice. Cell types are labeled. The
white dotted line defines the shadow left by
CXC6GFP+ cells on the TRITC-dextran channel.
(E) Quantification of the IVM images in (D).
(F) iNKT cell localization measured using anti-
CD45 infusion in neutrophil-depleted and isotype-
treated mice after i.v. a-Galcer treatment.
(G) iNKT cell activation status measured using
CD69 expression in neutrophil-depleted or iso-
type-treated mice after i.v. a-Galcer treatment.
Error bars represent SEM. *p < 0.05. n = 3–5 ani-
mals/group. See also Figure S2B.To determine the role of neutrophils in changing iNKT cell
behavior, we utilized antibody-mediated depletion of neutro-
phils. It is worth noting that this approach did not affect the
monocyte population in the lung (Figure S2B). Surprisingly, in
mice depleted of neutrophils, iNKT cell extravasation was signif-
icantly impaired, as assessed using IVM shadowing and flow3264 Cell Reports 16, 3260–3272, September 20, 2016cytometry (Figures 3E and 3F). As seen
in Figure 3D, there were fewer large
flattened iNKT cells (characteristic of
interstitial location) observed outside of
the vasculature in neutrophil-depleted
mice. Indeed, most iNKT cells displayed
shadows in TRITC-dextran-stained blood
vessels. Moreover, neutrophil depletion
led to impairment in iNKT cell activation
after a-Galcer administration (Figure 3G).
However, there were still some iNKT cells
activated, presumably those that were
already in the interstitium. We concluded
from these data that iNKT cell extravasa-
tion and activation were at least partly
dependent on the neutrophils guiding
the iNKT cells into the interstitium.
We further assessed whether neutro-
phil activation alone could induce iNKT
cell extravasation. Intratracheal adminis-
tration of the neutrophil-specific chemo-
kine keratinocyte chemoattractant (KC)
(200 ng) resulted in a marked increase in
neutrophil extravasation (Figures 4A and4B). Interestingly, administration of KC alone also resulted in
extravasation of iNKT cells despite the fact that iNKT cells did
not express receptors for KC (Figure S3). Approximately three
quarters of CXCR6GFP+ cells migrated into the interstitium after
KC, as assessed by the shadowing technique (Figure 4A).
We used flow cytometry to confirm that the extravasated
Figure 4. CCL17 Released by Neutrophils Guides Pulmonary iNKT Cells into the Interstitium
(A) IVM images and quantification of CXC6GFP+ cell localization based on the shadowing technique. Mice were treated with aerosolized KC only or intraperitoneal
CCL17-neutralizing antibody 30 min prior to KC. See also Figure S3.
(B and C) Neutrophil (B) and iNKT cell (C) localization based on CD45 IV staining after KC administration as in Figure 1E.
(D) Mean fluorescence intensity of CD69 on tetramer+ iNKT cells after treatment with aerosolized KC. a-Galcer treatment served as a positive control.
(legend continued on next page)
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CXCR6GFP+ cells were in fact iNKT cells (Figure 4C). Unlike with
a-Galcer treatment, KC administration resulted in only a modest
increase in CD69 expression in iNKT cells (Figure 4D). Clearly,
activated neutrophils could induce iNKT cell extravasation, but
a CD1d-dependent glycolipid is required for overt activation of
iNKT cells.
Neutrophils Release CCL17 to Guide iNKT Cell
Extravasation
Next, we systematically examined which molecules were
responsible for guiding iNKT cells out of the vasculature in
response to a-GalCer treatment. Blocking G-protein coupled re-
ceptors (GPCRs) with pertussis toxin prevented iNKT extravasa-
tion after a-Galcer, suggesting that chemokines were likely
involved (Figure 4E). The chemokine receptors CXCR3,
CXCR6, and CCR4 have all been shown to mediate iNKT cell
chemotaxis (Thomas et al., 2003). Blocking CXCR3 or neutral-
izing its ligand MIG had little to no effect on iNKT cell migration
out of the vasculature in response to a-Galcer treatment (Fig-
ure 4F and MIG data not shown). CXCR6 deficiency also failed
to inhibit emigration of iNKT cells out of the vasculature (data
not shown). To inhibit CCR4, we blocked the ligand CCL17
and found complete inhibition of iNKT cell emigration in
response to a-GalCer treatment (Figure 4F). Blocking CCL17
also inhibited KC-induced neutrophil-dependent iNKT cell
extravasation (Figure 4B). These data support the idea that neu-
trophils mediate the extravasation of iNKT cells from the vascu-
lature by potentially stimulating the release of CCL17.
Next, we sought to determine the source of CCL17 in the lung
after a-Galcer treatment. In naive animals, neutrophils in the
lungs were positive for CCL17. Surprisingly, as early as 3 hr after
a-Galcer administration, the expression of CCL17 in neutrophils
decreased significantly (Figure 4G). This release of CCL17 is
quite profound, given that neutrophil frequency in the lung in-
creases 10- to 20-fold between 2–4 hr after i.v. a-Galcer admin-
istration. These data indicate that activated neutrophils release
CCL17 upon a-Galcer administration.
Monocyte-Derived Dendritic Cells in the Lung Are Able
to Present Antigen to iNKT Cells
Although neutrophils imparted a crucial role in iNKT cell extrav-
asation, there was a lack of iNKT-neutrophil interactions, as
determined by using our imaging (data not shown). Therefore,
it was unlikely that neutrophils presented antigen to iNKT cells.
We hypothesized that antigen-presenting cells (APCs) existed
in the lung interstitium that were crucial for both early and late
iNKT cell activation. We used fluorescently labeled b-Galcer,
an a-Galcer derivative, to identify these APCs (Arora et al.,
2014). 12–18 hr after treatment, a population of cells that bound
the b-Galcer were visualized. This strategy does not accurately
reflect when the cells start binding b-Galcer (presumably much(E) IVM was used to assess and quantify pulmonary CXCR6GFP+ cell localization in
for 15–24 hr.
(F) IVM was used to assess and quantify pulmonary CXCR6GFP+ cell localization in
isotype control followed by i.v. a-Galcer for 15–24 hr. Error bars represent SEM.
(G) Intracellular CCL17 staining was assessed in neutrophils and moDCs 3 hr
a-Galcer-treated, red-filled. Mann-Whitney (two-tailed, non-parametric) statistica
3266 Cell Reports 16, 3260–3272, September 20, 2016earlier than 12 hr) but, rather, which cells bound and accumu-
lated most of the antigen. The b-Galcer binding cells were
observed outside of the vasculature (Figures 5A and 5C), and
their shape and size closely resembled that of CD11c+ DCs in
the lungs (Figure 5B). These extravascular cells actively sampled
the capillaries using their pseudopods and interacted with anti-
genic particles from the bloodstream (Movie S8). These cells
were identified as CD103 CD11c+ MHCIIhi DCs (Table S1).
The cells also expressed Ly6C, Mar1, and CD64, suggesting a
monocytic origin (Table S1; Plantinga et al., 2013; Jakubzick
et al., 2008).
We next addressed the importance of these DCs in iNKT cell
activation and extravasation. Complete ablation of circulating
monocytes and DCs by administering chlodronate-loaded
liposomes (CLLs) and diphtheria toxin (DT), respectively, to
CD11c-DTRmice depleted all detectable DCs in the interstitium,
abrogated activation and extravasation of pulmonary iNKT cells,
and reduced recruitment of neutrophils into the lung (Figures 5D–
5F). It is worth mentioning that CCR2hi monocytes are capable of
differentiating into pulmonary DCs and ccr2/ mice (CCR2KO)
have an impairment in dendritic cell maturation and activation
(Jakubzick et al., 2008; Chiu et al., 2004). However, iNKT cell
activation and neutrophil recruitment were intact in CCR2KO
mice (Figure S4C). This might be expected because another
set of CD103-negative, CD11b-high monocyte-derived DCs
that do not require CCR2 for migration have been identified in
lungs (Jakubzick et al., 2008).
It has been shown previously that, upon a-Galcer administra-
tion, iNKT cell-licensed CD8a+ DCs in the spleen produce
CCL17, which acts as a chemoattractant for CD8+ T cells
(Semmling et al., 2010). Interestingly, we found that monocyte-
derived DCs (moDCs) in the lungs also produce CCL17 for up
to 24 hr after a-Galcer administration.Whenwe gated onmoDCs
and assessed CCL17 production, we found an increase in
CCL17 starting at 3 hr that continued on to 24 hr (Figure 4G;
data not shown). This constitutive production of CCL17 by
moDCs may restrain iNKT cells in the interstitial space, prevent-
ing them from migrating further into the airspace after a-Galcer
administration.
iNKT Cell Extravasation Is Protective in S. pneumoniae
Infections
S. pneumoniae is a clinically important Gram-positive respiratory
pathogen that is capable of causing severe disease in humans.
It has recently been shown that S. pneumoniae harbors an
iNKT cell-specific glycolipid on its cell surface, and mice lacking
iNKT cells are far more susceptible to this infection (Kinjo
et al., 2011). Thus, we asked how iNKT cells would behave
upon infection with this complex pathogen. Intratracheal infec-
tion with S. pneumoniae resulted in changes to iNKT cell
behavior similar to that observed after a-Galcer administration.mice pretreated with pertussis toxin or saline control followed by i.v. a-Galcer
mice pretreated with CCL17-neutralizing antibody anti-CXCR3 antibodies, or
***p < 0.005. n = 3–5 animals/group.
after i.v. a-Galcer treatment. Isotype, gray-filled; naive (control), blue-filled;
l analysis was performed. **p < 0.01.
A B C
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Figure 5. Dendritic Cells Residing in an Extravascular Position Are the Major Cell Type to Take Up a-Galcer and Are Crucial to iNKT Cell
Activation
(A) Mice were injected i.v. with the probe b-Galcer for 12–18 hr. Shown is an IVM image of a b-Galcer+ cell.
(B) IVM image of a CD11c+ DC in the lung.
(C) Flow cytometry and anti-CD45 infusion were used to determine the localization of CD11c+ MHCIIhi cells. See also Figure S6B and Table S1.
(D) CD11c-DTRmice were depleted of monocytes and CD11c+ DCs using i.v. administration of CLL (200 mL) and intraperitoneal administration of DT 24 hr prior to
a-Galcer treatment.
(E) The activation level of iNKT cells was assessed based on the mean fluorescence intensity of CD69 on tetramer-positive cells.
(F) Localization of iNKT cells based on CD45 i.v. staining as in Figure 1E.
(G) Neutrophil influx in the lung 30 min after a-Galcer treatment in mice depleted of monocytes and dendritic cells.
Error bars represent SEM. **p < 0.01. n = 3–5 animals/group. See also Figure S4.Twenty-four hours post-infection, iNKT cells predominantly
crawled and, by 48 hr, were mostly stationary (Figure 6A). We
confirmed that these cells had migrated into the interstitium us-
ing IVM shadowing and flow cytometry (Figures 6B and 6C).
iNKT cells extravasated 48 hr after S. pneumoniae infection as
opposed to 24 hr with a-Galcer (Figures 6B and 6C). These
data suggest a similar response of iNKT cells to a-Galcer treat-
ment and S. pneumoniae infection, albeit with a delayed
response to the pathogen.
Mice that lacked iNKT cells were highly susceptible to
S. pneumoniae infection (Kawakami et al., 2003; Figure 6D), as
were mice deficient in neutrophils (data not shown). To test
whether the increasedmortalitywasdue to thewave of iNKT cells
following neutrophils into the infectedmice, we blocked iNKT cell
extravasation by blocking CCL17 in mice infected with
S. pneumoniae.Although neutrophils still migrated into the lungs,
presumably via pathogen-associated molecular patterns and
other stimuli associated with a complex infection, iNKT cells no
longer followed when CCL17 was blocked (Figure S5). By 24 hr,
we see that about 60% of iNKT cells in S. pneumoniae-infected
mice are extravascular. In the presence of CCL17-neutralizing
antibody alone, iNKT cell localization is similar to control mice,
with the majority of cells (75%) being intravascular (Figure S5).
A very similar increase inmortality was observedwhenCC17was
blocked in mice as whenmice lacked iNKT cells (Figure 6D). This
indicated that extravasation of iNKT cells out of the vasculature is
crucial for survival and mounting an effective immune response
against pulmonary infection with S. pneumoniae.DISCUSSION
In this study,weanalyzed thebehavior andmechanismsof activa-
tion of pulmonary iNKT cells using IVM. In vivo imaging provided
us with significant insights into iNKT cell responses in the lung.
Therewas a striking and distinct behavior of pulmonary iNKT cells
versus those in other organs in response to either a CD1d antigen
or an infectious agent likeS. pneumoniae. In the lung, under basal
conditions, iNKT cells predominately reside in the vasculature,
and a small population resides in the interstitium. Upon activation,
pulmonary iNKTcellsmigratedoutof thevasculature into the inter-
stitium. Thisbehavior is considerably different fromwhat hasbeen
observed in other organs. Interestingly, neutrophils guide iNKT
cells into the interstitial space, and, while the neutrophils continue
into thealveoli, the iNKTcells arrest as they come intocontactwith
antigen-presenting cells, including monocyte-derived dendritic
cells. Very few, if any, iNKT cells ever migrated into the airways.
We found that the CD11c+ monocyte-derived DCs and perhaps
other subtypes of DCs were the main antigen-presenting cells in
the lung based on their ability to effectively take up the reporter
b-Galcer. In the absence of these DCs, neutrophil and iNKT cell
activation and recruitment into the interstitium were severely hin-
dered.Thenet effectof thiswell-choreographedprocess involving
multiple immune cell types is that infections like S. pneumoniae
are effectively dealt with. However, the interruption of any of these
processes leads to increased mortality.
Our working model shown in Figure 7 is that, upon administra-
tion of either a-Galcer or S. pneumoniae, a CD1d-bearing DC inCell Reports 16, 3260–3272, September 20, 2016 3267
Figure 6. iNKTCell Behavior after S. pneumoniae Infection Emulates that Observed after a-Galcer Treatment, andCCL17 Signaling Is Crucial
for Survival of S. pneumoniae Infections
(A) Quantification of CXCR6GFP+ iNKT cell behavior after aerosolized S. pneumoniae using IVM.
(B) Quantification of CXCR6GFP+ iNKT cell localization based on IVM and TRITC-dextran shadowing in mice infected with S. pneumoniae.
(C) Quantification of iNKT cell localization after S. pneumoniae based on CD45 IV staining and flow cytometry.
(D) Survival analysis of mice treated with CCL17-neutralizing antibody. Survival was significantly different between CCL17-treated mice and control mice based
on a Mantel-Cox test (p = 0.006).
Error bars represent SEM. n = 3–5 animals/group. See also Figure S5.the interstitium presents glycolipid antigen to interstitial iNKT
cells, and this leads to rapid recruitment of neutrophils into the
interstitium. Neutrophils guide iNKT cells from the vasculature
into the interstitium via CCL17. Although the major population
of iNKT cells resides in the vasculature, it is critical to note that
there is a smaller population of iNKT cells, a pioneer iNKT cell,3268 Cell Reports 16, 3260–3272, September 20, 2016in the tissue under basal conditions. These cells have been re-
ported as primarily an IL17-producing subset (Lee et al., 2015).
iNKTs have also previously been correlated with the increase
in MIP-2 in the lungs of S. pneumoniae-infected mice (Kawakami
et al., 2003). Activation of the Th17 arm of immunity as well as the
production of MIP-2 potently induces neutrophil recruitment
Figure 7. Working Model of Pulmonary iNKT Cell Behavior during Steady State and upon Activation
Under steady-state conditions, 80% of pulmonary iNKT cells reside in the vasculature, patrolling it, and 25% of pulmonary iNKT cells reside in the lung
interstitial space.
(1) Ninety-five percent of DCs, both conventional and moDCs, also reside outside of the lung vasculature. moDCs, in steady state, sampled the lung vasculature
with their pseudopods. During infection, moDCs capture antigens in the vasculature, such as a-Galcer or S. pneumoniae-derived glycolipid, and present these
antigens to interstitial iNKT cells.
(2) This induces a robust increase in neutrophil recruitment into the lungs through an unknownmechanism. Neutrophils extravasate out of the vasculature into the
interstitium, releasing CCL17, and continue migrating into the airways.
(3) Vascular iNKT cells follow the neutrophils into the interstitium in aCCL17-dependent manner.When in the interstitium, extravasated iNKT cells come in contact
with moDCs. moDCs are able to produce CCL17 as well and cause iNKT cells to cease further migration out into the airways, retaining them in the interstitial
space.
(4) There, the iNKT cells become fully activated and assist with the clearance of infections.(Liang et al., 2007). Although there is presently no way of disso-
ciating the functions of the tissue and vascular iNKT cell popula-
tions, the fact that neutrophil recruitment began as early as
30 min and was dependent upon CD1d strongly supports a
role for interstitial cells. In fact, these pioneer iNKT cells may
function as the sentinel immune cells for S. pneumoniae, and
this may explain why iNKT cell-deficient mice die as quickly as
neutrophil-deficient mice. Whether extravascular iNKT cells or
DCs are the source of the neutrophil chemoattractants was not
investigated in this study. However, a companion paper by Xu
et al. (2016) explores the complex dynamic interplay and two-
way cross-talk between these cells. The authors identified that
the neutrophil recruitment could be induced by the iNKT-DC
interaction, the DCs were the source of the chemoattractant,
and prostaglandins were an important component of the
response. There is a striking similarity in cell types and mecha-
nisms of action described using in vitro human systems by Xu
et al. (2016), and our own in vivo data in the mouse lung.
Although infections in the liver caused iNKT cells to become
activated, no emigration out of the liver vasculature was ever
noted (Lee et al., 2010). Similarly, in the spleen, in response to
S. pneumoniae, Barral et al., (2012) observed that patrolling
iNKT cells arrested in the marginal zone help with effector func-
tions, including eradication of S. pneumoniae in this organ.
Finally, in joints (Lee et al., 2014) and intestine (data not shown),we found that iNKT cells are already located outside of the
vasculature, and, in the former, they tend to abut the blood ves-
sels, keeping pathogens from infiltrating into this tissue. How-
ever, in none of these organs have we observed migration of
iNKT cells out of the vasculature in response to pathogens. It is
intriguing that the iNKT cells were not able to emigrate out of
the vasculature in the absence of neutrophils. In fact, we identi-
fied that neutrophils were critical for guiding iNKT cells across
the endothelium and into the interstitial space. The mechanism
by which this occurs makes use of CCL17, amolecule previously
reported to be important to induce iNKT cell chemotaxis. In a
previous study of airway hyper-responsiveness (AHR), mice defi-
cient for CCR4 (CCL17 receptor) did not develop AHR (Meyer
et al., 2007). The group concluded that the CCR4 receptor on
iNKT cells was important for their localization in the lung (Meyer
et al., 2007). Our study extends this observation to highlight the
crucial role of the CCR4/CCL17 axis in iNKT cell emigration into
the interstitium in response to infections. We found that neutro-
phils release CCL17 when they are recruited to the lung and
extravasate into the lung interstitium. Although neutrophil
release of CCL17 is short-lived, moDCs are able to upregulate
CCL17 for as long as 24 hr after treatment with a-Galcer. This
concert of events—neutrophils guiding iNKT cells out of the
lung vasculature andmoDCs retaining iNKT cells in the intrastitial
space by producing CCL17—is crucial for iNKT cell activation.Cell Reports 16, 3260–3272, September 20, 2016 3269
There appears to be an inherent trait of emigrating neutrophils
to recruit iNKT cells. A single neutrophil-specific chemokine (KC)
with no other stimulus was sufficient to induce iNKT cells to
follow the neutrophils out of the vasculature. Recently, it has
been reported that, during influenza infections, neutrophils ap-
peared to guide CD8 T cells into airways via trails of CXCL12 pre-
sent on their elongated uropods (Lim et al., 2015). Although we
have similarly noticed these long tails form across the endothelial
barrier, potentially suggesting a similar mechanism of action, the
importance of these tails relative to release of soluble chemo-
kines remains to be determined. Interestingly, although the neu-
trophils continued emigration past the interstitium and onward to
the alveoli, the iNKT cells remained in the very small space be-
tween the endothelium of the capillaries and epithelium of the
alveoli (Figure 2D; data not shown). Using b-Galcer, we identified
that the most prominent antigen-presenting cells were localized
in the interstitium and presumably bound the iNKT cells, over-
riding any further follow-me signals from the neutrophils.
Our intravital data would suggest that, although these mono-
cyte-derived DCs were in an extravascular position, they were
able to extend their processes into the bloodstream and sample
for antigens (Movie S8). This may explain why i.v. administration
of a-Galcer could activate interstitial iNKT cells in less than
30 min to induce very rapid neutrophil recruitment. Although
elaborate, this would be an elegant way of detecting and re-
sponding to pathogens and noxious stimuli that are systemic
or airborne. Moreover, a chemokine gradient into the interstitium
could be set up via an interstitial cell.
In this study, we have established that iNKT cells can cross the
vasculature in response to the activating ligand a-Galcer. This
behavior was very specific for pulmonary iNKT cells. We identify
that neutrophils are critical for guiding the iNKT cells, perhaps
because neutrophils have the proteases necessary for breaching
this barrier. We also identify the molecule that functions as a
guidance cue: the chemokine CCL17. Blocking this chemokine
prevented iNKT cell extravasation, leading to increasedmortality
in an infection model. The fact that even a generic neutrophil
chemokine, KC, resulted in the extravasation of iNKT cells raises
the possibility that, in some inappropriate lung inflammatory pro-
cesses such as asthma, chronic obstructive pulmonary disease
(COPD), and fibrosis, blocking CCL17 could resolve or reduce
the ongoing inflammation and provide some therapeutic benefit
(Kim, et al., 2005; Paget and Trottein, 2013).
EXPERIMENTAL PROCEDURES
Mice
6- to 8-week-old C57BL/6 (B6), CD1d/ (CD1dKO), Ja18/ (Ja18KO),
cd11c-DTR (CD11c-DTR), CD11c-EYFP (CD11c-YFP), ccr2/ (CCR2KO),
and B6.CXCR6-GFP knockin (CXCR6GFP+) mice were purchased from The
Jackson Laboratory. All mice were housed under specific pathogen-free, dou-
ble-barrier unit at the University of Calgary. Mice were fed autoclaved rodent
feed and water ad libitum. All protocols used were in accordance with the
guidelines drafted by the University of Calgary Animal Care Committee and
the Canadian Council on the Use of Laboratory Animals.
IVM
Multichannel spinning disk confocal intravital microscopy was used to image
mouse lungs. The setup was adapted fromwork described previously (Looney
et al., 2011). In brief, mice were anaesthetized (10 mg/kg xylazine hydrochlo-3270 Cell Reports 16, 3260–3272, September 20, 2016ride and 200 mg/kg ketamine hydrochloride), and the body temperature was
maintained at 37C using a heating pad (CU-201, Live Cell Instruments). The
right jugular vein was cannulated to administer fluorescent dyes and additional
anesthetic. The trachea of the mouse was exposed, and a small catheter was
threaded into the trachea. The catheter was then attached to a small rodent
ventilator (Harvard Apparatus). The mouse was placed into the right lateral de-
cubitus position, and three ribs were removed to expose the lung. The lung
was stabilized with a small suction chamber as described previously (Looney
et al., 2011). Images were acquired with an upright microscope (BX51,
Olympus) using a 203/0.95 W numerical aperture (NA) water-dipping XLUM
Plan F1 objective (Olympus). The microscope was equipped with a confocal
light path (WaveFx, Quorum) based on a modified Yokogawa CSU-10 head
(Yokogawa Electric). A 512 3 512 pixel back-thinned electron multiplying
charge-coupled device camera (C9100-13, Hamamatsu) was used for fluores-
cence detection. Simultaneous behavior of multiple cell types in the lung was
assessed using three (488-, 561-, and 635-nm) laser excitation wavelengths
(Cobalt) in rapid succession and visualized with the appropriate long-pass fil-
ters (Semrock). Volocity software (PerkinElmer) was used to acquire and
analyze images (Wong et al., 2011; McDonald et al., 2010).
In Vivo Labeling for IVM
Anesthetized mice were given fluorescently labeled antibodies (below) and/or
TRITC-dextran (Life Technologies) i.v. via the jugular vein prior to imaging.
Neutrophils were identified with 2 mg of AF647-conjugated Ly6G, clone 1A8
(eBioscience). The vasculature was identified with 2 mg of R-Phycoerythrin
(PE)-labeled CD31 (PECAM-1, eBioscience). For shadowing experiments,
500 mg of TRITC-dextran was administered.
In Vivo Labeling of APCs
C11 TopFluor galactosyl ceramide N-[11-(dipyrrometheneboron difluoride)
undecanoyl]-D-galactosyl-b1-10-D-erythro-sphingosine, referred to in the
text as ‘‘b-gal,’’ was used to identify APCs that captured and presented glyco-
lipids to iNKT cells. b-Gal (Avanti) was prepared as described previously (Arora
et al., 2014) and was administered i.v. 12–18 hr prior to experiments. All indi-
cated mice were treated i.v. with 2 mg.
Agonist Administration
a-Galcer (Kirin Brewery) was administered i.v. (2 mg in saline) or intratracheally
(400 ng in saline) prior to the indicated time during experiments.
Bacterial Growth and Infection
Streptococcus pneumoniae strain D39 was grown on blood agar plates over-
night at 37C with CO2. Single colonies were picked from plates and grown for
10–12 hr in brain heart infusion medium (BHI) broth at 37C with CO2 and no
shaking. When an optical density 600 (OD600) of 0.5 was reached, bacteria
were resuspended in PBS, andmice were given 30–35 mL of suspension (aero-
solized) to achieve a dose of 1–3 3 105 colony-forming units (CFUs) per
mouse.
Aerosolization into Mouse Airways
This was performed with a rodent aerosolization kit (PennCentury). All animals
that were treated via the intratracheal route received 30–35 mL of aerosolized
compounds. Mice were treated with 200 ng of KC (R&D Systems), 400 ng of
a-Galcer, and 1–3 3 105 CFUs of S. pneumoniae. Aerosolized saline (30–
35 mL) was used for control in mice we labeled untreated.
CCL17 Blockade
100 mg of anti-mouse CCL17-neutralizing antibody (MAB529, R&D Systems)
was given intraperitoneally (i.p.) 30 min prior to treatment with a-Galcer or
S. pneumoniae.
In Vivo Labeling of Vascular Leukocytes for Flow Cytometry
Mice were anesthetized with ketamine and xylazine (200 and 10 mg/kg,
respectively). 3 mg of PE-Cy7-labeled anti-CD45 (eBioscience) was injected
in a total volume 150 mL of sterile saline i.v. via the tail vein. Body temperature
was maintained at 37C. Mice were sacrificed 10 min after administration of
the antibody. The lung was exsanguinated by perfusing cold PBS from the
right ventricle and then harvested for flow cytometric analysis.
Flow Cytometry
Mice were euthanized with CO2. Lungs were perfused with 10 mL of ice-cold
saline injected through the right ventricle of the heart. Perfused lungs were
removed, minced, and placed in digestion buffer (PBS with 1 mg/mL collage-
nase type X1 and 60 U DNase) (Sigma). Lungs were digested for 30 min and
passed through a 70-mm filter. Residual red blood cells were lysed using
ammonium chloride potassium (ACK) (Gibco). The cells were blocked using
2.4G2 (BioXcell) for 30 min. Cells were stained for 30 min with the indicated
markers. Cells were stained with PE-labeled anti-mouse CD1d (1B1), CD69
(HI.2F3), CD103 (M290), CD205 (205yekta), I-A/I-E (M/114.15.2), PBS-57-
loaded or unloaded CD1d tetramer, or SiglecF (E50-2440); APC, Alexa Fluor
647- or eFluor 660-labeled anti-mouse Ly6G (1A8), SiglecF (E50-2440),
CD11c (N418), CD64 (X54-5/7.1), FcεR1 (MAR-1), or PBS-57-loaded or un-
loaded CD1d tetramer; PerCP-Cy5.5-labeled anti-mouse CD45 (30-F11),
CD3e (145-2C11), or Ly6C (HK1.4); PE-Cy7-labeled anti-mouse CD11b (M1/
70), or CD45 (30-F11); eFluor 450-labeled anti-mouse CD45R (RA3-6B2) or
fixable viability dye; and APC-eFluor 780-labeled anti-mouse F4/80 (BM8).
All antibodies were from eBioscience, BD Biosciences, or the NIH tetramer
core unless indicated otherwise. Samples were run using a FACSCanto flow
cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star).
For the iNKT cell study, cells were gated as shown in Figure S6A. For the
monocyte-derived DC cell study, cells were gated as shown in Figure S6B.
CCL17 Staining
Treated mouse lungs were perfused, removed, and immediately fixed and
minced in 2 mL of eBioscience IC fixation buffer (eBioscience) for 3 min, allow-
ing for immediate fixation of epitopes (Patel et al., 2015). Lungs were minced
and passed through a 70-mm filter and washed with excess fluorescence-acti-
vated cell sorting (FACS) buffer (PBS + 2% BSA). Cells were permeabilized by
incubation in PBS + 0.3% Triton X-100 (Sigma-Aldrich) solution for 15 min at
4C. Endogenous biotin was blocked (endogenous biotin blocking kit, Life
Technologies), followed by incubation with antibody cocktail. Biotinylated
anti-mouse CCL17 antibody (BAF529, R&D Systems) was included in the
antibody cocktail. The staining was carried out in FACS buffer + 0.1% Triton
X-100. PE-streptavidin (eBioscience) conjugate was used for secondary
staining.
Whole-Mount Staining
Mice were euthanized by overdosing with ketamine and xylazine, and then
their lungs were inflated using 4% low-melting agarose (Invitrogen). When
the agarosewas cooled, the lungswere sliced into 300-mmslices using a vibra-
tome (Leica). Lungs were blocked in PBS + 1%BSA and 2 mg FC block (2.4G2)
for 1 hr and then stained in a solution of PBS + 1%BSA with a 1:200 dilution of
loaded or unloaded tetramer (NIH tetramer core) for 12–17 hr at 4C. Samples
were washed in PBS + 1%BSA five to ten times and immediately imaged using
an inverted Nikon A1Rsi confocal microscope or an inverted Leica TSC SP8
confocal microscope.
Depletion Experiments
For neutrophil depletion, 200 mg of anti-GR1 antibody (clone RB6-8C5,
BioXcell) was administered i.p. 24 hr prior to experiments. It is important to
note that we did not observe depletion in the monocyte population upon
administration of anti-GR1 (data not shown). Nevertheless, mice deficient in
CCR2 lacking inflammatory monocytes had responses very similar to wild-
type (WT) mice. To deplete CD11c+ DCs, 80 ng of DT was given intraperitone-
ally 48 hr prior to experiments to CD11c-DTR mice. Monocytes were depleted
with i.v. administration (200 mL) of CLL 24 hr before experiments. CD11c-DTR
animals were used for DC and monocyte depletion.
Statistical Analysis
Statistical analysis was performed using PRISM software (GraphPad). All
values are expressed as mean ± SEM. Data were compared using one-way
ANOVA with Bonferroni multiple comparisons post hoc test. CCL17 expres-
sion was compared using Mann-Whitney U test (two-tailed, non-parametric).Survival analysis was assessed using a Mantel-Cox test. Statistical signifi-
cance was accepted at p < 0.05.
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